HONG KONG – Underscoring the clouds hanging over China’s pharmaceutical and biotechnology industries, Shanghai Pharmaceuticals Holding Co Ltd. reported double-digit growth in the third quarter of the year, but the mostly positive results were tarred by coming in below expectations. Read More
HONG KONG – 3SBio Inc. has acquired the patents for a new drug to treat renal failure from the Shanghai Institute of Materia Medica (SIMM) as part of its efforts to expand its offerings linked to diseases of the kidney. Read More
HONG KONG – A common respiratory virus previously believed to cause only mild respiratory tract infections in children can cause more serious, life-threatening infections in adults than seasonal influenza, according to the findings of the largest retrospective cohort study of the respiratory syncytial virus (RSV) conducted in Asia to date. Read More
HONG KONG – A South Korean biopharmaceutical firm is taking increasingly aggressive steps into the China market through a series of collaborations. Read More
• Samsung Biologics, of Seoul, South Korea, and Roche AG, of Basel, Switzerland, said they entered a long-term strategic manufacturing agreement under which Samsung will manufacture Roche’s commercial biologic medicines at its two manufacturing facilities in Incheon, South Korea. Terms were not disclosed. Read More
